Endologix 2009 Third Quarter Financial Results Conference Call  Today's Calls

· Shareholder.com · Shareholder.com Webcasting Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other Oct 27 Calls Today's Calls

Call Details Endologix 2009 Third Quarter Financial Results Conference Call Tue, Oct 27, 2009, 5:00 pm Eastern Listen to the archived event audio About Endologix (NasdaqGM:ELGX) Endologix, Inc. engages in the development, manufacture, marketing, and sale of minimally invasive therapies for the treatment of vascular diseases. It offers Powerlink System, a catheter and endoluminal graft for the treatment of abdominal aortic aneurysm, a weakening of the wall of the aorta, an artery of the body. The Powerlink System consists of a self-expanding cobalt chromium alloy stent cage covered with an ePTFE graft; and is implanted in the abdominal aorta that is accessed through the femoral artery. Its Powerlink System shunts away the blood flow from the weakened or aneurysmal section of the aorta, reducing pressure and potential for the aorta to rupture. The Powerlink System includes infrarenal bifurcated systems, and aortic cuffs and limb extensions; and IntuiTrak to deliver and deploy the Powerlink stent graft. It sells its products primarily in the United States, Europe, and Japan. The company was formerly known as Radiance Medical Systems, Inc. and changed its name to Endologix, Inc. in May 2002. Endologix, Inc. was founded in 1992 and is based in Irvine, California. More Info: Quote | Chart | News | Profile | Reports | Research | Msgs | Insider | Financials | Analyst Ratings